Biocon Biologics, one of India's leading biologic drug manufacturers ... in adult patients with moderate to severe chronic plaque psoriasis (PsO)," said the company, which will present the ...

BRIDGEWATER, N.J., and BENGALURU, India, March 7 ... in adult patients with moderate to severe chronic plaque psoriasis (PsO). The data are being presented at the 2025 American Academy of ...

While the Big Pharma didn’t drill down into the data for the Iconic-Advance 1&2 studies, the company did use the conference to reinforce the findings from a previous phase 3 plaque psoriasis win ...